DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Younossi ZM, Ratziu V, Loomba R. et al; REGENERATE Study Investigators.
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
Lancet 2019;
394 (10215): 2184-2196
We do not assume any responsibility for the contents of the web pages of other providers.